Clinical trial
ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma
NCT00352313 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00352313 |
|---|---|
| Title | ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma |
| Official title | A Phase I/II Study of ATN-161 and Carboplatin in Adult Patients With Recurrent Intracranial Malignant Glioma |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | ATN-161, carboplatin |
| Enrollment | 82 |
| Start date | May 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Jul 14, 2006 |
| Last update posted | May 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: